PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Nov-2024 Pentixapharm Releases Interim Report for the Third Quarter of 2024 Pentixapharm Holding AG
12-Nov-2024 Novo Holdings co-leads $181.4 million Series D financing in Alentis Therapeutics to advance groundbreaking antibody-drug conjugates (ADCs) for solid tumours Novo Holdings
12-Nov-2024 iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates iTeos
12-Nov-2024 Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets Mainz BioMed N.V.
12-Nov-2024 CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update CureVac
12-Nov-2024 Terumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment Journey Terumo Blood and Cell Technologies
12-Nov-2024 Kancera focuses on cardiovascular diseases Kancera
12-Nov-2024 ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights ONWARD Medical N.V.
12-Nov-2024 Santhera Enters into Exclusive Supply Agreement for AGAMREE® (Vamorolone) with Ali Al Suwaidi Trading Establishment (ASTE) in Qatar Santhera Pharmaceuticals
12-Nov-2024 SMC recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
12-Nov-2024 Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins (news with additional features) Medios AG
12-Nov-2024 Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine Marinomed Biotech AG
12-Nov-2024 Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites Lonza Group AG
12-Nov-2024 AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2024 AEVIS VICTORIA SA
12-Nov-2024 DINAMIQS opens new lab in Zurich Siegfried AG
11-Nov-2024 Formycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard Formycon AG
11-Nov-2024 PUSHING 2PP BOUNDARIES: NEW NANOONE GREEN INTRODUCES 515 NM LASER CAPABILITY UpNano GmbH
11-Nov-2024 Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers Gilead Sciences Ltd
11-Nov-2024 SMC recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
11-Nov-2024 Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Autolus Therapeutics